Parachlorophenylalanine exacerbates oxidative stress induced by gentamicin in rats

Basic and Clinical Pharmacology and Toxicology

Volumn 97, Issue 3, 2005, Pages 174-178

  Muñoz Castañeda, Juan R ^a   Montilla, Pedro ^a,c   Muñoz, Maria C ^a   Bujalance, Immaculada ^a   Muntané, Jordi ^b   Túnez, Isaac ^a  

^a Universidad de Cordoba   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FENCLONINE; GENTAMICIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; GLUTATHIONE METABOLISM; KIDNEY DYSFUNCTION; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OTOTOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEINURIA; RAT; SEROTONIN RELEASE; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

ANIMALS; BLOOD UREA NITROGEN; BRAIN; BRAIN CHEMISTRY; CATALASE; CREATININE; DRUG SYNERGISM; FENCLONINE; GENTAMICINS; GLUTATHIONE; KIDNEY; KIDNEY DISEASES; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PROTEINURIA; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN ANTAGONISTS; SUPEROXIDE DISMUTASE;

RATTUS NORVEGICUS;

EID: 24744432059     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2005.pto_973141.x     Document Type: Article

References (43)

1. Ademuyiwa, O., E. O. Ngaha & F. O. Ubah: Vitamin E and selenium in gentamicin nephrotoxicity. Hum. Exp. Toxicol. 1990, 9, 281-288.
2. Aebi, H.: Catalase in vitro. Meth. Enzymol. 1984, 105, 121-126.
3. Ali, B. H. & Ak. Bashir: Effect of superoxide dismutase treatment on gentamicin nephrotoxicity in rats. Gen. Pharmacol. Vas. 1996, S27, 349-353.
4. Benítez-King, G., I. Tunez, A. Bellon, G. G. Ortiz & G. Anton-Tay: Melatonin prevents cytoskeletal alterations and oxidative stress induced by okadaic acid in N1E-115 cells. Exp. Neurol. 2003, 182, 151-159.
5. Chan, T. Y. & P. L. Tang: Characterization of the antioxidant effects of melatonin and related indoleamines in vitro. J. Pineal Res. 1996, 20, 187-191.
6. Ciaccio, M., M. Valenza, L. Tesoriere, A. Bongiorno, R. Albiero & M. A. Livrea: Vitamin A inhibits doxorubicin-induced membrane lipid peroxidation in rat tissues in vivo. Arch. Biochem. Biophys. 1993, 302, 105-108.
7. Cuzzocrea, S., E. Masón, L. Dugo, I. Serraino, R. Di Paola, D. Britti, A. De Sarro, S. Pierpaoli, A. Caputi, E. Masini & D. Salvemini: A role for superoxide in gentamicin-mediated nephropathy in rats. Eur. J. Pharmacol. 2002, 450, 67-76.
8. Daniels, W. M., S. J. van Rensburg, J. M. van Zyl, B. J. van der Walt & J. J. Taljaard: Free radical scavenging effects of melatonin and serotonin: possible mechanism. Neuroreport 1996, 7, 1593-1596.
9. Deeb, S. A., K. A. Moutaery, H. A. Khan & M. Tariq: Exacerbation of imiodipropionitrile-induced behavioral toxicity, oxidative stress, and vestibular hair cell degeneration by gentamicin in rats. Neurotoxicol. Teratol. 2000, 22, 213-220.
10. Dulon, D., C. Aurousseau, J. Erre & J. Aran: Relationship between the nephrotoxicity and ototoxicity induced by gentamicin in the guinea pig. Acta Otolaryngol. 1988, 106, 219-225.
11. Edson, R. S. & C. L. Terrell: The amynoglucosides. Mayo Clin. Proc. 1999, 74, 519-528.
12. Erdem, A., N. U. Gundogan, A. Usubutun, K. Kilinc, S. R. Erdem, A. Kara & A. Bozkurt: The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats. Nephrol. Dial. Transplant. 2000, 15, 1175-1182.
13. Guidet, B. F. & S. V. Shan: In vivo generation of hydrogen peroxide by rat kidney cortex and glomeruli. Amer. J. Physiol. 1989, 256, F158-F164.
14. Halmagyi, G. M., C. M. Fattore, I. S. Curthoys & S. Wade: Gentamicin vestibulotoxicity. Otolaryngol. Head Neck Surg. 1994, 111, 1749-1752.
15. Ichikawa, I., S. Kimaya & T. Yoshioka: Renal antioxidant enzymes: Their regulation and function. Kidney Int. 1994, 45, 1-9.
16. Ikonomov, O. C., A. G. Stoynev, I. I. Goranova-Stoyneva, A. Popov & V. A. Minkova: Nephrotoxic effect of the specific brain serotonin depletory para-chlorophenylalanine. Acta Phys. Hung. 1990, NS-H76, 191-199.
17. Kumar, K. V., A. A. Shifow, M. U. Naidu & K. S. Ratnakar: Carvedilol: a beta blocker with antioxidant property protects against gentamicin-induced nephrotoxicity in rats. Life Sci. 2000, 66, 2603-1611.
18. Leon, J., D. Acuña-Castroviejo, R. M. Sainz, J. C. Mayo, D. X. Tan & R. J. Reiter: Melatonin and mitochondrial function. Life Sci. 2004, 75, 765-790.
19. Liu, J. & A. Mori: Monoamine metabolism provides an antioxidant defense in the brain against oxidant- and free radical-induced damage. Arch. Biochem. Biophys. 1993, 302, 118-127.
20. Maldonado, P. D., D. Barrera, I. Rivero, R. Mata, O. N. Medina-Campos, R. Hernández-Pando, R. & J. Pedraza-Chaverri: Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage. Free Radic. Biol. Med. 2003, 35, 317-324.
21. Matuszak, Z., K. Reszka & C. F. Chignell: Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations. Free Radic. Biol. Med. 1997, 23, 367-372.
22. 1 receptors. J. Physiol. Biochem. 2003, 59, 263-268.
23. Montilla, P., I. Túnez, M. C. Muñoz, M. J. Delgado & M. Salcedo: Hyperlipidemic nephropathy induced by adriamycin in ovariectomized rats: role of free radicals and effect of 17-beta-estradiol administration. Nephron 2000, 85, 65-70.
24. Montilla, P., I. Túnez, M. C. Muñoz, A. López & J. V. Soria:. Hyperlipidemic nephropathy induced by adriamycin: effect of melatonin administration. Nephron 1997, 76, 345-350.
25. Montilla-Lopez, P., I. Túnez-Fiñana, M. C. Muñoz de Agueda, F Gascón-Luna & J. V. Soria-Lopez: Protective role of melatonin and retinol palmitate in oxidative stress and hyperlipidemic nephropathy induced by adriamycin in rats. J. Pineal Res. 1998, 26, 86-93.
26. Montilla-López, P., M. C. Muñoz-Águeda, M. Feijóo-López, J. R. Muñoz-Castañeda, I. Bujalance-Arenas & I. Túnez-Fiñana: Comparison of melatonin versus vitamin C on oxidative stress and antioxidant enzyme activity in Alzheimer's disease induced by okadaic acid in neuroblastoma cells. Eur. J. Pharmacol. 2002, 451, 237-243.
27. Orret, F. A., P. J. Brooks, E. G. Richardson & S. Mohammed. Paeditric nosocomial urinary tract infection at a regional hospital. Int. Urol. Nephrol. 1999, 31, 173-179.
28. Ozbek, E., Y. Turkoz, E. Sahna, F. Ozugurlu, B. Mizrak & M. Ozbek: Melatonin administration prevents the nephrotoxicity induced by gentamicin. Brit. J. Urol. Int. 2000, 85, 742-746.
29. Park, J. W., Y. C. Youn, O. S. Kwon, Y. Y. Jang, E. S. Han & C. S. Lee: Protective effect of serotonin on 6-hydroxydopamine- and dopamine-induced oxidative damage of brain mitochondria and synaptosomes and PC12 cells. Neurochem. Int. 2002, 40, 223-233.
30. Pedraza-Chaverri, J., D. Barrera, P. D. Maldonado, Y. I. Chirino, N. A. Macias-Ruvalcaba, O. N. Medina-Campos, L. Castro, M. I. Salcedo & R. Hernández-Pando: S-allylmercaptocysteine scavenges hydroxyl radical and singlet oxygen in vitro and attenuates gentamicin-induced oxidative and nitrosative stress and renal damage in vivo. B.M.C. Clin. Pharmacol. 2004, 4, 5.
31. Pedraza-Chaverri, J., P. D. Maldonado, O. N. Madina-Campos, I. M. Olivares-Corichi, M. A. Granados-Silvestre, R. Hernández-Pando & M. E. Ibarra-Rubio: Garlic ameliorates gentamicin nephrotoxicity: relation to antioxidant enzymes. Free Radic. Biol. Med. 2000, 29, 602-611.
32. Ramos, A. J., P. Tagliaferro, J. J. López-Costa, E. M. López, J. P. Saavedra & A. Brusco: Neuronal and inducible nitric oxide synthase immunoreactivity following serotonin depletion. Brain Res. 2002, 958, 112-121.
33. Sha, S. H. & J. Schacht: Formation of reactive oxygen species following bioactivation of gentamicin. Free Radic. Biol. Med. 1999, 26, 341-347.
34. Sharma, H. S., T. Winkler, E. Stalberg, S. Mohanty & J. Westman: p-Chlorophenylalanine, an inhibitor of serotonin synthesis reduces blood-brain barrier permeability, cerebral blood flow, edema formation and cell injury following trauma to the rat brain. Acta Neurochir. 2000, 76, 91-95.
35. Snyder, S. H., J. Axelrod & M. A. Zweig: A sensitive and specific fluorescence assay for tissue serotonin. Biochem. Pharmacol. 1965, 14, 831-835.
36. Sun, Y., L. W. Oberley & Y. Li: A simple method for clinical assay of superoxide dismutase. Clin. Chem. 1988, 34, 479-500.
37. Tagliaferro, P., A. J. Ramos, J. J. Lopez-Costa, E. M. Lopez, J. P. Saavedra & A. Brusco: Increased nitric oxide synthase activity in a model of serotonin depletion. Brain Res. Bull. 2001, 54, 187-191.
38. Túnez, I., M. C. Muñoz, M. Feijóo-López, M. E. Valdelvira, I. Bujalance-Arenas & P. Montilla: Effect of melatonin on hyperlipidemic nephropathy under constant light exposure. J. Physiol. Biochem. 2002, 58, 109-114.
39. Túnez, I., M. C. Muñoz, M. Feijóo, M. E. Valdelvira, J. R. Muñoz-Castañeda & P. Montilla: Melatonin effect on renal oxidative stress under constant light exposure. Cell Biochem. Funct. 2003a, 21, 35-40.
40. Túnez, I., M. C. Muñoz, M. Feijõo, J. R. Muñoz-Castañeda, I. Bujalance, M. E. Valdelvira & P. Montilla: Protective melatonin effect on oxidative stress induced by okadaic acid into rat brain. J. Pineal Res. 2003b, 34, 265-268.
41. Vatassery, G. T., K. S. SantaCruz, E. G. DeMaster, H. T. Quach & W. E. Smith: Oxidative stress and inhibition of oxidative phosphorylation induced by peroxynitrite and nitrite in rat brain subcellular fractions. Neurochem. Int. 2004, 45, 963-970.
42. Walker, P. D., Y. Barri & S. V. Shah: Oxidant mechanisms in gentamicin nephrotoxicity. Ren. Fail. 1999, 21, 433-442.
43. Yang, C. L., X. H. Du, & Y. X. Han: Renal cortical mitochondrial are the source of oxygen free radicals enhanced by gentamicin. Ren. Fail. 1995, 17, 21-26.